Innovation, Research
Therapeutic innovation in the fight against pulmonary arterial hypertension
… cardiopulmonary disease characterised by intense remodelling of the small-calibre pulmonary arteries. Either … (without a proven cause) or hereditary (linked to a genetic abnormality), it affects approximately 15 people per … known as vascular remodelling. As this remodelling impedes the flow of blood through the vessels of the lungs, the …
Published on: